Literature DB >> 2798871

Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy.

D J Meyerhoff1, M D Boska, A M Thomas, M W Weiner.   

Abstract

Phosphorus-31 magnetic resonance (MR) spectroscopy was performed on the liver of patients with alcoholic hepatitis (n = 10), alcoholic cirrhosis (n = 9), and viral hepatitis B (n = 3) and on healthy control subjects (n = 21). A hydrogen-1 MR image-guided localization technique (ISIS) was used to acquire P-31 spectra selectively from a volume of interest within the liver. Spectra were analyzed to yield absolute molar concentrations of hepatic phosphomonoesters, phosphodiesters, inorganic phosphate, and adenosine triphosphate. It was found that (a) hepatic metabolite ratios in alcoholic liver disease were not significantly different from those in healthy subjects, (b) absolute hepatic metabolite concentrations were decreased by 25%-46% in alcoholic hepatitis and 13%-50% in alcoholic cirrhosis compared with those in healthy subjects, and (c) hepatic intracellular pH was 7.4 in healthy subjects, more acidic in alcoholic cirrhosis, and more alkaline in alcoholic hepatitis. The findings indicate that hepatic metabolite ratios are not a sensitive measure of alcoholic liver disease, that quantitative P-31 MR spectroscopy is able to noninvasively show metabolic changes associated with alcoholic liver disease, and that alcoholic hepatitis and cirrhosis may be distinguished by means of hepatic intracellular pH measured with MR spectroscopy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2798871     DOI: 10.1148/radiology.173.2.2798871

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver.

Authors:  Z Tosner; M Dezortová; J Tintĕra; M Hájek
Journal:  MAGMA       Date:  2001-08       Impact factor: 2.310

2.  Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.

Authors:  Monika Dezortova; Pavel Taimr; Antonin Skoch; Julius Spicak; Milan Hajek
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models.

Authors:  R Jalan; J Sargentoni; G A Coutts; J D Bell; K Rolles; A K Burroughs; S D Taylor Robinson
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

4.  Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes.

Authors:  Manal F Abdelmalek; Mariana Lazo; Alena Horska; Susanne Bonekamp; Edward W Lipkin; Ashok Balasubramanyam; John P Bantle; Richard J Johnson; Anna Mae Diehl; Jeanne M Clark
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

5.  In vivo, high-field, 3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease.

Authors:  A Orlacchio; F Bolacchi; M Angelico; A Mancini; V Cozzolino; M Cadioli; G Simonetti
Journal:  Radiol Med       Date:  2008-04-02       Impact factor: 3.469

6.  Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.

Authors:  Bengt Norén; Peter Lundberg; Marcus Ressner; Staffan Wirell; Sven Almer; Orjan Smedby
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

7.  Free magnesium levels in normal human brain and brain tumors: 31P chemical-shift imaging measurements at 1.5 T.

Authors:  J S Taylor; D B Vigneron; J Murphy-Boesch; S J Nelson; H B Kessler; L Coia; W Curran; T R Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

8.  Phosphorus-31 nuclear magnetic resonance in vivo spectroscopy of human liver during hepatitis A virus infection.

Authors:  Y Yamane; M Umeda; T O'uchi; T Mitsushima; K Nakata; S Nagataki
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

Review 9.  In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.

Authors:  Ladislav Valkovič; Marek Chmelík; Martin Krššák
Journal:  Anal Biochem       Date:  2017-01-21       Impact factor: 3.365

10.  In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts.

Authors:  S D Taylor-Robinson; J Sargentoni; J D Bell; E L Thomas; C D Marcus; K K Changani; N Saeed; H J Hodgson; B R Davidson; A K Burroughs; K Rolles; C S Foster; I J Cox
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.